Characterization of the 5-hydroxytryptamine receptors mediating contraction in the pig isolated intravesical ureter

British Journal of Pharmacology

Volumn 138, Issue 1, 2003, Pages 137-144

  Hernández, Medardo ^a   Barahona, María Victoria ^b   Simonsen, Ulf ^c   Recio, Paz ^a   Rivera, Luis ^a   Martínez, Ana Cristina ^a   García Sacristán, Albino ^a   Orensanz, Luis M ^d   Prieto, Dolores ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c AARHUS UNIVERSITY   (Denmark)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

5 HT agonists and antagonists; 5 HT 2A receptors; 5 hydroxytryptamine; Pig intravesical ureter; Smooth muscle contraction

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; 1 (4 AMINO 5 CHLORO 2 METHOXYPHENYL) 3 (1 BUTYL 4 PIPERIDINYL) 1 PROPANONE; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4,5,7A,8,9,10,11,11A OCTAHYDRO 10 METHYL 7H INDOLO[1,7 BC][2,6]NAPHTHYRIDINE; 5 CARBAMOYLTRYPTAMINE; ALPHA ADRENERGIC RECEPTOR; ALPHA METHYLSEROTONIN; AZASETRON; CYANOPINDOLOL; GUANETHIDINE; MONOAMINE OXIDASE INHIBITOR; PARGYLINE; PHENTOLAMINE; PHYSOSTIGMINE; RITANSERIN; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1A AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 3 AGONIST; SEROTONIN 4 AGONIST; SEROTONIN RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; SODIUM CHANNEL; SPIPERONE; TETRODOTOXIN; UNINDEXED DRUG;

ADRENERGIC TRANSMISSION; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; MUSCLE CONTRACTILITY; MUSCLE TONE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; SMOOTH MUSCLE; SWINE; SYMPATHETIC NERVE; URETER;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUANETHIDINE; MALE; MUSCLE CONTRACTION; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RITANSERIN; SEROTONIN; SPIPERONE; SWINE; TETRODOTOXIN; TRYPTAMINES; URETER; URINARY BLADDER; UROTHELIUM;

EID: 0242600789     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705019     Document Type: Article

References (30)

1. BJORK, L., CORNFIELD, L.J., NELSON, D.L., HILLVER, S.E., ANDEN, N.E., LEWANDER, T. & HACKSELL, U. (1991). Pharmacology of the novel 5-hydroxytryptaminel A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects. J. Pharmacol. Exp. Ther., 258, 58-65.
2. BLOK, C., VAN VENROOIJ, G.E., MOKHLESS, I. & COOLSAET, B.L. (1985). Dynamics of the ureterovesical junction: its fluid transport mechanism in the pig. J. Urol., 134, 175-178.
3. BOESS, F.G. & MARTIN, I.L. (1994). Molecular biology of 5-HT receptors. Neuropharmacology, 33, 275-317.
4. CHEN, H.I. (1990). Evidence for the presynaptic action of 5-hydroxytryptamine and the involvement of purinergic innervation in the rabbit lower urinary tract. Br. J. Pharmacol., 101, 212-216.
5. 2 receptors. J. Urol., 143, 1037-1040.
6. 1A receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein. J. Pharmacol. Exp. Ther., 290, 1195-1201.
7. 4 receptor agonists, RS 67333 and RS 67506 in vitro and in vivo. Br. J. Pharmacol., 115, 1387-1392.
8. ENGEL, G., GOTHER, M., HOYER, D., SCHLICKER, E. & HILLEBRAND, K. (1986). Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in rat brain cortex with 5-HT1B binding sites. Naunyn Schmiedebergs' Arch. Pharmacol., 332, 1-7.
9. FETISSOF, F., DUBOIS, M.P., ARBEILLE-BRASSART, B., LANSON, Y., BOIVIN, F. & JOBARD, P. (1983). Endocrine cells in the prostate gland, urothelium and Brenner tumors. Immunohistological and ultrastructural studies. Virchows Arch. B. Cell Pathol. Incl. Mol. Pathol., 42, 53-64.
10. 3 receptor antagonist. Eur. J. Pharmacol., 196, 299-305.
11. 4 receptor. Br. J. Pharmacol., 111, 332-338.
12. GIDENER, S., GUMUSTEKIN, M. & KIRKALI, Z. (1999). Pharmacological analysis of 5-hydroxytryptamine effects on human isolated ureter. Pharmacol. Res., 39, 487-491.
13. GIDENER, S., KIRKALI, Z. & GUVEN, H. (1995). Influence of serotonin on the human ureter: an in vitro pharmacological study. Urol. Int., 55, 202-204.
14. HANDSCHUMACHER, R.E. & VANE, J.R. (1967). The relationship between the penetration of tryptamine and 5-hydroxytryptamine into smooth muscle and the associated contractions. Br. J. Pharmacol., 29, 105-118.
15. HAUSER, D.S., MEVISSEN, M., WEISS, R., PORTIER, C.J., SCHOLTYSIK, G., STUDER, U.E. & DANUSER, H. (2002). Effects of ketanserine and DOI on spontaneous and 5-HT-evoked peristalsis of the pig ureter in vivo. Br. J. Pharmacol., 135, 1026-1032.
16. 2B adenosine receptors mediate relaxation of the pig intravesical ureter: adenosine modulation of non adrenergic non cholinergic excitatory neurotransmission. Br. J. Pharmacol., 126, 969-978.
17. HERNÁNDEZ, M., PRIETO, D., ORENSANZ, L.M., BARAHONA, M.V., GARCÍA-SACRISTÁN, A. & SIMONSEN, U. (1995). Nitric oxide is involved in the non-adrenergic non-cholinergic inhibitory neurotransmission of the pig intravesical ureter. Neurosci. Lett., 186, 33-36.
18. HERNÁNDEZ, M., PRIETO, D., SIMONSEN, U., RIVERA, L., BARAHONA, M.V. & GARCÍA-SACRISTÁN, A. (1992). Noradrenaline modulates smooth muscle activity of the isolated intravesical ureter of the pig through different types of adrenoceptors. Br. J. Pharmacol., 107, 924-931.
19. HERNÁNDEZ, M., SIMONSEN, U., PRIETO, D., RIVERA, L., GARCÍA, P., ORDAZ, E. & GARCÍA-SACRISTÁN, A. (1993). Different muscarinic receptor subtypes mediating the phasic activity and basal tone of pig isolated intravesical ureter. Br. J. Pharmacol., 110, 1413-1420.
20. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev., 46, 157-203.
21. HUMPHREY, P.P. (1984). Peripheral 5-hydroxytryptamine receptors and their classification. Neuropharmacology, 23, 1503-1510.
22. KILPATRICK, G.J., BUTLER, A., BURRIDGE, J. & OXFORD, A.W. (1990). 1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist. Eur. J. Pharmacol., 182, 193-197.
23. KLARSKOV, P. & HØRBY-PETERSEN, J. (1986). Influence of serotonin on lower urinary tract smooth muscle in vitro. Br. J. Pharmacol., 58, 507-513.
24. MARÍN, J., SALAICES, M. GOMEZ, B. & LLUCH, S. (1981). Noradrenergic component in the vasoconstriction induced by 5-hydroxytryptamine in goat cerebral arteries. J. Pharm. Pharmacol., 33, 715-719.
25. MESSORI, E., RIZZI, C.A., CANDURA, S.M., LUCCHELLI, A., BALESTRA, B. & TONINI, M. (1995). 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle. Br. J. Pharmacol., 115, 677-683.
26. NOZULAK, J., KALKMAN, H.O., FLOERSHEIM, P., HOYER, D., SCHOEFFER, P. & BUERKI, H.R. (1995). (+)-cis-4, 5, 7a, 8, 9, 10, 11, 11a-octahydro-7H-10-methylindolo[1, 7-bc][2, 6]-naphthyridine: a 5HT2C/2B receptor antagonist with low 5HT2A receptor affinity. J. Med. Chem., 38, 28-33.
27. PRIETO, D., HERNÁNDEZ, M., RIVERA, L., GARCÍA-SACRISTÁN, A. & SIMONSEN, U. (1997). Distribution and functional effects of neuropeptide Y on equine ureteral smooth muscle and resistance arteries. Regul. Pept., 69, 155-165.
28. SAXENA, P.R., DE VRIES, P. & VILLALȮN, C.M. (1998). 5-HT1-like receptors: a time to bid goodbye. Trends Pharmacol. Sci., 19, 311-316.
29. TONINI, M., MESSORI, E., FRANCESCHETTI, G.P., RIZZI, C.A., CASTOLDI, A.F., COCCINI, T. & CANDURA, S.M. (1994). Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle. Br. J. Pharmacol., 113, 1-2.
30. WAIKAR, M.V., FORD, A.P.D.W. & CLARKE, D.E. (1994). Evidence for an inhibitory 5-HT4 receptor in urinary bladder of Rhesus and Cynomolgus monkeys. Br. J. Pharmacol., 111, 213-218.